Table 4. Performance of LFIs on plasma samples using Trombley assay as bench mark assay*.
| Sensitivity (95% CI) | Specificity (95% CI) | |
|---|---|---|
| SD Ebola Zaire Ag | 110/156 | 170/171 |
| 70.51 (62.69–77.53)a | 99.42 (96.78–99.99)c | |
| ReEBOV Antigen test Kit | 133/156 | 142/171 |
| 85.26 (78.70–90.42)b,c | 83.04 (76.56–88.34)d | |
| One step Ebola test | 138/154 | 144/170 |
| 89.61 (83.68–93.94)b | 84.71 (78.40–89.76)d | |
| DEDIATEST EBOLA | 108/154 | 147/171 |
| 70.13 (62.24–77.23)a | 85.96 (79.84–90.80)d | |
| altona PCR | 129/156 | 172/172 |
| 82.69 (75.83–88.27)c | 100.00 (97.88–100.00) |
* Only samples with RT-PCR results for both altona and Trombley assays are included. LFI products with different superscripts for sensitivity or specificity have a statistically significant difference in performance (p<0.05)